Most compounded versions of popular drugs used for weight loss including Wegovy and Zepbound may soon no longer be available after a U.S. judge declined an initial injunction to allow compounding ...

ALEXANDRIA, VA, UNITED STATES, January 26, 2026 / EINPresswire.com / — The Alliance for Pharmacy Compounding (APC) today announced a new, exclusive accreditation partnership with Coalition for ...

May 29—(StatePoint) Most consumers know how a traditional pharmacy works. Far fewer are aware of an alternative option: a compounding pharmacy. Here's everything you need to know about these ...

It is easy to differentiate between your local community pharmacy and a large pharmaceutical manufacturer. The pharmacy is viewed as dispensing medications to particular patients with prescriptions ...

Some Compounded GLP-1s Remain Legal Experts Warn of Risks Oral GLP-1 Drugs Some Sources Riskier Than Others Illegal GLP-1 Drugs The U.S. Food and Drug Administration (FDA) has told compounding ...

Compounded GLP-1 drugs aren't FDA-approved and may carry unknown safety risks. Experts warn of inconsistent quality, dosing and possible side effects in compounded meds. Lifestyle habits—like diet, ...

As of April 22, many compounding pharmacies will have to stop selling their own versions of the popular weight loss drugs Ozempic and Wegovy. That’s because the FDA has determined the shortage of ...

The MarketWatch News Department was not involved in the creation of this content. Lawsuit alleges anti-competitive conduct designed to suppress lawful compounding pharmaceuticals and limit patient ...

Strive Compounding Pharmacy sues Eli Lilly and Novo Nordisk over alleged GLP-1 weight loss drug competition limits. Read more here.